PORTLAND, Ore., and PLEASANTON, Calif., Sept. 28 /PRNewswire/ -- Welch
Allyn Protocol, a leading supplier of patient monitoring technology, and
Mallinckrodt Inc. (NYSE: MKG), the market leader in the pulse oximetry
industry, today announced a new agreement which commits the parties to closer
cooperation in integrating state-of-the-art Nellcor pulse oximetry technology
in the Welch Allyn Protocol patient monitoring product line.
Welch Allyn Protocol, recognizing the strong end-user demand for the
latest oximetry technology to be incorporated in their devices, will work
closely with Nellcor to offer Nellcor oximetry solutions in Welch Allyn
Protocol monitors as they become available.
"This fits our go-forward model very well," said Doris Engibous, vice
president of Oximetry for Mallinckrodt. "We are partnering more closely than
ever before with our top-volume OEM customers to share our experience in
oximetry integration and to make sure that the products we develop take their
specific requirements in mind."
"Together we are much faster to market than working in isolation," said
Bill Bednarski, vice president, OEM & Licensing Technology, Mallinckrodt.
"This is very good news for all clinicians who have been trusting Nellcor
oximetry for so many years."
"Mallinckrodt's Nellcor brand of pulse oximetry is the acknowledged market
leader in the industry," said Robert F. Adrion, president & CEO of Welch Allyn
Protocol. "Our customers ask for Nellcor oximetry compatibility in our
products by name. We are very pleased to be strengthening our relationship
with Mallinckrodt."
Engibous added, "We have been doing business with both Welch Allyn and
Protocol for years and, quite frankly, would not be in the position we are
today without that support. As Welch Allyn and Protocol come together, it is
a great opportunity to contribute to their leadership positions."
A. About Welch Allyn Protocol
Welch Allyn Protocol, Inc. designs, manufactures and markets
mission-critical flexible monitoring solutions that improve patient care
and lower healthcare operating costs. Welch Allyn Protocol uses innovative
computer and software technologies to provide vital patient data and connect
clinicians with mobile patients via workstations, wireless devices and the
Internet. Welch Allyn Protocol is a wholly owned subsidiary of Welch Allyn,
Inc. and is based in Beaverton, Oregon. Its products are available in more
than 90 countries around the world.
B. About Welch Allyn
Welch Allyn, Inc. was founded in 1915 and is today a leading global
manufacturer and marketer of innovative medical equipment and miniature
precision lamps. Today, Welch Allyn, Inc. is recognized by frontline
providers as the leading trusted supplier of a comprehensive line of medical
devices to detect, diagnose and manage disease. Headquartered in Skaneateles
Falls, New York, USA, Welch Allyn, Inc. has more than 1,800 employees and
numerous manufacturing, sales and distribution facilities located throughout
the world. Welch Allyn's website is http://www.welchallyn.com .
C. About Mallinckrodt
Mallinckrodt Inc. is a global manufacturer and marketer of specialty
medical products designed to sustain breathing, diagnose disease and relieve
pain. Named one of America's most admired medical products and equipment
companies by Fortune magazine, Mallinckrodt does business in more than 100
countries. In fiscal 2000, combined net sales were $2.7 billion for
Mallinckrodt's respiratory, imaging and pharmaceutical product lines.
Mallinckrodt's Nellcor Oximetry Business is the world leader in pulse oximetry
with over 80 OEM and Licensing partners, 16 sensor choices, over 50 corporate
account and IHN purchasing contracts, and four generations of pulse oximetry
technology. Based in St. Louis, Missouri, Mallinckrodt's website address is
http://www.mallinckrodt.com .
SOURCE Mallinckrodt Inc.
 back to top
Related links:
http://www.Mallinckrodt.com
CONTACT:
Media, Barbara Abbett, 314-654-5230, email,
barbara.abbett@mkg.com, or Investors, Robert Martsching,
314-654-3190, email, Invest@mkg.com, both of Mallinckrodt Inc.,;
or Grant Gibson of Welch Allyn Protocol, 503-526-4372, email,
grantg@protocol.com; or Joyce McMahon, 978-468-1155, ext. 1152,
email, joyce.mcmahon@mullen.com, or Kara Nadeau, 978-468-1155,
ext. 2146, email, knadeau@mullen.com, both of Mullen
|
